NOTE: The Federal Drug Administration (FDA) has not yet approved this procedure. However, Dr. Gordon M. Castleberry has received extensive training and performed this procedure on patients outside the United States. When the FDA approves this procedure, Dr. Castleberry will be one of only 200 physicians in the U.S. trained to perform this minimally invasive prostate cancer treatment.
High intensity focused ultrasound, or HIFU, is a therapy option for localized prostate cancer that may offer a balance between eliminating cancer and maintaining quality of life. It is an outpatient, radiation-free procedure from which patients can truly walk away.
HIFU is a minimally invasive treatment option for patients diagnosed with organ confined prostate cancer. HIFU uses precisely focused ultrasound waves that, when delivered, raise the temperature of the targeted prostate tissue. This rapid-firing heat destroys the targeted tissue while leaving structures outside the focal zone unharmed.
With the precision and flexibility HIFU offers, patients, with Dr. Castleberry, can decide on a customized treatment plan tailored to their prostate cancer diagnosis.
HIFU Treatment Options
Standard HIFU Procedure
The standard HIFU procedure ablates the entire prostate gland. This is the most appropriate choice of HIFU procedures for patients who have organ confined prostate cancer that is not limited to one separate area of the prostate. The benefits of a standard HIFU procedure include:
- 92 percent of patients are successfully treated
- Over 99 percent of men remain continent
- 70 percent of men retain erectile function
- Usually a day case
- Non surgical
- No radiation
- The procedure can be repeated as necessary and does not rule out other treatment options
Focal HIFU Therapy
Focal HIFU is an emerging technique for the treatment of prostate cancer where only the tumor is treated instead of the whole prostate gland. Focal HIFU is intended to increase the likelihood of avoiding important structures located around the prostate, which could reduce side effects. It may be suitable for men with low or intermediate risk cancer who have a single tumor inside the prostate or several tumors all on the same side of the gland.
Salvage Treatment with HIFU
HIFU may be performed on patients with histologically confirmed, locally recurrent, organ-confined, non-metastatic prostate cancer following any form of treatment for prostate cancer. This form of treatment is often referred to as a salvage treatment. A clinician will have to determine if the patient is a candidate for salvage HIFU. This procedure does not hinder future options for treatment if a patient’s prostate cancer should return after a HIFU procedure.